Key Events This Week
8 June: Technical momentum shifts amid mixed market signals
12 June: Intraday high with 7.59% surge to Rs.560.4
12 June: Week closes at Rs.554.10 (+1.87%) outperforming Sensex
Jun 15, 03:30 PM
BSE+NSE Vol: 2.76 lacs

Vimta Labs Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a robust day change of 6.34%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a recent downgrade in its Mojo Grade from Hold to Sell.
Read full news article
8 June: Technical momentum shifts amid mixed market signals
12 June: Intraday high with 7.59% surge to Rs.560.4
12 June: Week closes at Rs.554.10 (+1.87%) outperforming Sensex

The Sensex gained 1.16% on 12 Jun 2026, yet Vimta Labs Ltd outpaced both the benchmark and its sector peers with a robust 7.59% intraday surge, reaching a high of Rs 560.4. This 3.39 percentage-point outperformance over the Medical Equipment/Supplies/Accessories sector’s 2.99% gain signals a distinctly stock-specific momentum shift.
Read full news article
Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Vimta Labs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong day change of 6.30%, the company’s overall technical and fundamental outlook remains cautious, with a recent downgrade in its Mojo Grade to Sell from Hold.
Read full news article
The Sensex declined 0.28% on 03 Jun 2026 while Vimta Labs Ltd surged 7.19%, marking a 4.16 percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which has been on a positive trajectory over the past week.
Read full news article
Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Vimta Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Vimta Labs Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a 1.43% gain on 11 May 2026, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a downgrade in its Mojo Grade from Hold to Sell.
Read full news articleIntimation of Schedule of Analyst/ Institutional Investor Meet
Newspaper Publication - AGM & Annual Report
Annual Report for the FY 2025-26
No Upcoming Board Meetings
Vimta Labs Ltd has declared 100% dividend, ex-date: 18 Jun 26
Vimta Labs Ltd has announced 2:10 stock split, ex-date: 24 Feb 06
Vimta Labs Ltd has announced 1:1 bonus issue, ex-date: 13 Jun 25
No Rights history available